Wei Ren
Fortuna: 99 905 $ al 31/05/2026
Fortuna: 99 905 $ al 31/05/2026
Wei Ren is currently an Independent Non-Executive Director at Ascentage Pharma Group International Co., Ltd. since 2019.
Prior to this, he was a Partner at Jingtian & Gongcheng Law Firm starting from 2003.
Mr. Ren completed his graduate and undergraduate degrees at Peking University in 2003.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 20/04/2026 | 19.954 ( 0,01 % ) | 99 905 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Director/Miembro de la Junta | 13/06/2019 |
Jingtian & Gongcheng Law Firm
Jingtian & Gongcheng Law Firm Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/01/2009 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Peking University
Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jingtian & Gongcheng Law Firm
Jingtian & Gongcheng Law Firm Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Ascentage Pharma Group International Co., Ltd.
Ascentage Pharma Group International Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering, developing and commercializing of therapies for hematological malignancies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.